肿瘤药学
腫瘤藥學
종류약학
ANTI-TUMOR PHARMACY
2014年
6期
426-429
,共4页
丁思娟%唐朝晖%何宝桂%廖遇平
丁思娟%唐朝暉%何寶桂%廖遇平
정사연%당조휘%하보계%료우평
宫颈癌%放射敏感性%洛铂%细胞凋亡
宮頸癌%放射敏感性%洛鉑%細胞凋亡
궁경암%방사민감성%락박%세포조망
Cervical carcinoma%Radiosensitivity%Lobaplatin%Cell apoptosis
目的:观察洛铂对人宫颈癌细胞(Hela细胞)放射敏感性的影响,并初步探讨其机制。方法将体外培养的Hela细胞分为空白组、低浓度洛铂组、高浓度洛铂组、空白+照射组、低浓度洛铂+照射组、高浓度洛铂+照射组,单次照射6 Gy,比较各组细胞的存活情况,并通过流式细胞术检测和比较各组细胞的凋亡情况及细胞周期分布。结果洛铂对Hela细胞生长有抑制作用。空白组、低浓度洛铂组、高浓度洛铂组细胞的D0值分别为1.76、1.42、0.86 Gy(F=4006.0,P=0.00),Dq值分别为1.99、1.37、0.92 Gy(F=3087.0,P=0.00),α值分别为0.085、0.254、0.262 Gy-1(F=614.6,P=0.00),β值分别为0.0652、0.181、0.234 Gy-2(F=1342.1,P=0.00)。空白组、低浓度洛铂组、高浓度洛铂组、空白+照射组、低浓度洛铂+照射组、高浓度洛铂+照射组的细胞凋亡率分别为(1.10±0.01)%、(1.01±.006)%、(2.32±0.03)%、(2.87±0.008)%、(2.96±0.02)%、(4.38±0.01)%(F=23.1,P=0.00)。洛铂可以阻滞细胞于G2/M期。结论洛铂对人宫颈癌细胞有放射增敏作用,其机制可能与促进细胞凋亡有关。
目的:觀察洛鉑對人宮頸癌細胞(Hela細胞)放射敏感性的影響,併初步探討其機製。方法將體外培養的Hela細胞分為空白組、低濃度洛鉑組、高濃度洛鉑組、空白+照射組、低濃度洛鉑+照射組、高濃度洛鉑+照射組,單次照射6 Gy,比較各組細胞的存活情況,併通過流式細胞術檢測和比較各組細胞的凋亡情況及細胞週期分佈。結果洛鉑對Hela細胞生長有抑製作用。空白組、低濃度洛鉑組、高濃度洛鉑組細胞的D0值分彆為1.76、1.42、0.86 Gy(F=4006.0,P=0.00),Dq值分彆為1.99、1.37、0.92 Gy(F=3087.0,P=0.00),α值分彆為0.085、0.254、0.262 Gy-1(F=614.6,P=0.00),β值分彆為0.0652、0.181、0.234 Gy-2(F=1342.1,P=0.00)。空白組、低濃度洛鉑組、高濃度洛鉑組、空白+照射組、低濃度洛鉑+照射組、高濃度洛鉑+照射組的細胞凋亡率分彆為(1.10±0.01)%、(1.01±.006)%、(2.32±0.03)%、(2.87±0.008)%、(2.96±0.02)%、(4.38±0.01)%(F=23.1,P=0.00)。洛鉑可以阻滯細胞于G2/M期。結論洛鉑對人宮頸癌細胞有放射增敏作用,其機製可能與促進細胞凋亡有關。
목적:관찰락박대인궁경암세포(Hela세포)방사민감성적영향,병초보탐토기궤제。방법장체외배양적Hela세포분위공백조、저농도락박조、고농도락박조、공백+조사조、저농도락박+조사조、고농도락박+조사조,단차조사6 Gy,비교각조세포적존활정황,병통과류식세포술검측화비교각조세포적조망정황급세포주기분포。결과락박대Hela세포생장유억제작용。공백조、저농도락박조、고농도락박조세포적D0치분별위1.76、1.42、0.86 Gy(F=4006.0,P=0.00),Dq치분별위1.99、1.37、0.92 Gy(F=3087.0,P=0.00),α치분별위0.085、0.254、0.262 Gy-1(F=614.6,P=0.00),β치분별위0.0652、0.181、0.234 Gy-2(F=1342.1,P=0.00)。공백조、저농도락박조、고농도락박조、공백+조사조、저농도락박+조사조、고농도락박+조사조적세포조망솔분별위(1.10±0.01)%、(1.01±.006)%、(2.32±0.03)%、(2.87±0.008)%、(2.96±0.02)%、(4.38±0.01)%(F=23.1,P=0.00)。락박가이조체세포우G2/M기。결론락박대인궁경암세포유방사증민작용,기궤제가능여촉진세포조망유관。
Objective To investigate the effects of Lobaplatin on the radiosensitivity of human cervical carcinoma and its mechanisms. Methods Hela cells cultured invitro were assigned to the blank group, low concentration Lobaplatin group, high concentration Lobaplatin group, blank+radiation group, low concentration Lobaplatin+radiation group and high con-centration Lobaplatin+radiation group, single light 6 Gy. Flow cytometry was applied to detect the cell apoptosis and cell cycle. Results Lobaplatin had inhibition on the growth of cervical cancer Hela cells. The Do numericals of the blank group, low concentration Lobaplatin group and high concentration Lobaplatin group were 1.76, 1.42 and 0.86 Gy (F=4006.0, P=0.00) respectively, the Dq numericals were 1.99, 1.37 and 0.92 Gy (F=3087.0, P=0.00) respectively, theαnumericals were 0.085, 0.254 and 0.262 Gy-1 (F=614.6, P=0.00) respectively, theβnumericals were 0.0652, 0.181 and 0.234 Gy-2 (F=1342.1, P=0.00) respectively. The cell apoptosis rates of the above six groups were respectively (1.10±0.01)%、(1.01 ±.006)%、(2.32±0.03)%、(2.87±0.008)%、(2.96±0.02)%、(4.38±0.01)%(F=23.1, P=0.00) . Lobaplatin could block cells in G2/M phase. Conclusion Lobaplatin could intensify the radiosensitivity of human cervical carcinoma cell, through enhancing the apoptosis.